Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
Trine L. Toft‐Bertelsen, Mads Gravers Jeppesen, Eva Tzortzini, Kai Xue, Karin Giller, Stefan Becker, Amer Mujezinovic, Bo Hjorth Bentzen, Loren B. Andreas, Antonios Kolocouris, Thomas N. Kledal, Mette M. Rosenkilde
Abstract
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
Topics & Concepts
AmantadineVirologyIn vitroCoronavirus disease 2019 (COVID-19)Ion channelSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyChemistryComputational biologyMedicineGeneticsInternal medicineReceptorDiseaseInfectious disease (medical specialty)Pharmacological Receptor Mechanisms and Effects